
24PXCFP01- Papillex CIN1/2
This survey will take no longer than 10 minutes to complete and is intended to assess your eligibility for the KGK Science Clinical Trial. This clinical trial will investigate the safety and efficacy of Papillex on the regression of abnormal cervical cells caused by HPV. All information collected will be kept in accordance with our Privacy Policy. https://kgkscience.com/about/privacy/
44Questions